Astrana Health, Inc. ASTH
Nasdaq · XNAS · stock · Services-Management Consulting Services · website · IPO 1999-04-09
Astrana Health, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $2.0B | $1.4B | $1.1B | $773.9M |
| Operating income | $78.5M | $89.3M | $84.6M | $104.3M | $98.2M |
| Interest expense | — | — | $16.1M | $7.9M | $5.4M |
| Income tax | $15.5M | $30.9M | $32.0M | $40.9M | $31.7M |
| Net income | $22.5M | $43.1M | $60.7M | $45.2M | $68.9M |
| EPS (diluted) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 |
| Operating cash flow | $114.6M | $52.2M | $68.2M | $82.1M | $70.3M |
| Free cash flow | $104.5M | $44.2M | $39.7M | $59.2M | $51.1M |
| Cash & equivalents | $429.5M | $288.5M | $293.8M | $288.0M | $233.1M |
| Total assets | $2.2B | $1.4B | $933.4M | $966.2M | $852.4M |
| Total liabilities | $1.7B | $840.7M | $522.6M | $407.7M | $336.4M |
| Shareholders' equity | $793.3M | $716.7M | $616.7M | $544.3M | $454.6M |
Source: SEC EDGAR filings · CIK 0001083446 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.